The Effects of Formularies and Other Cost Management Tools on Access to Medications: An Analysis of the MMA and the Final Rule, Jack Hoadley, Health Policy Institute, Georgetown University for the Kaiser Family Foundation, March 2005
http://www.kff.org/medicare/7299.cfm

A Comparison of Proposed and Final Regulations Governing Medicare Part D Plan Enrollment and Part D Benefit Appeal and Grievance Procedures, Sara Rosenbaum, George Washington University School of Public Health for the Kaiser Family Foundation, March 2005
http://www.kff.org/medicare/7300.cfm

Medicare Prescription Drug Law Fact Sheet, Kaiser Family Foundation, March 2005
http://www.kff.org/medicare/7044.cfm

Medicare Modernization Act Implementation Timeline, Kaiser Family Foundation, March 2005
http://www.kff.org/medicare/medicare_timeline.cfm

Summary of the Final Rule to Implement the New Medicare Prescription Drug Benefit, Health Policy Alternatives, Inc. for the Kaiser Family Foundation, February 2005
http://www.kff.org/medicare/7228.cfm

Estimates of Medicare Beneficiaries’ Out-of-Pocket Drug Spending in 2006: Modeling the Impact of the MMA, Jim Mays and Monica Brenner, Actuarial Research Corporation and Tricia Neuman, Juliette Cubanski, and Gary Claxton, Kaiser Family Foundation, November 2004
http://www.kff.org/medicare/med112204pkg.cfm

Views of the New Medicare Drug Law: A Survey of People on Medicare, Harvard School of Public Health and the Kaiser Family Foundation, August 2004
http://www.kff.org/medicare/pomr081004pkg.cfm

The New Medicare Drug Benefit: Potential Effects of Pharmacy Management Tools on Access to Medications, Haiden Huskamp and Nancy Keating for the Kaiser Family Foundation, July 2004
http://www.kff.org/medicare/7120a.cfm

Summary of the Medicare Prescription Drug, Improvement and Modernization Act of 2003, Health Policy Alternatives, Inc., for the Kaiser Family Foundation, January 2004
http://www.kff.org/medicare/med011604pkg.cfm

Medicare and Prescription Drugs Through Private Drug-Only Plans: A Discussion with Actuaries, Health Policy Alternatives, Inc. for the Kaiser Family Foundation, June 2003
http://www.kff.org/medicare/6086-index.cfm

Medicaid and Dual Eligible Prescription Drug Resources

The New Medicare Prescription Drug Law: Issues for Enrolling Dual Eligibles into Drug Plans, Richard Jensen for the Kaiser Commission on Medicaid and the Uninsured, January 2005
http://www.kff.org/medicaid/7242.cfm

Medicare’s New Prescription Drug Benefit: The Voices of People Dually Covered by Medicare and Medicaid, Lake Snell Perry and Associates, Inc. for the Kaiser Family Foundation, January 2005
http://www.kff.org/medicare/7243.cfm

The New Medicare Prescription Drug Law: Issues for Dual Eligibles with Disabilities and Serious Conditions, Jeff Crowley for Kaiser Commission on Medicaid and the Uninsured, July 2004
http://www.kff.org/medicaid/7119.cfm

Medicaid Outpatient Prescription Drug Benefits: Findings from a National Survey, 2003, Jeff Crowley and Deb Ashner, Georgetown University, and Linda Elam, Kaiser Commission on Medicaid and the Uninsured, December 2003
http://www.kff.org/medicaid/4164.cfm

One State's Medicaid Managed Care Formulary Operations: A Look at Pennsylvania, 2001-2002, Gene Bishop, University of Pennsylvania School of Medicine, March 2005
http://www.kff.org/medicaid/7297.cfm

General Prescription Drug Resources

Follow the Pill: Understanding the U.S. Commercial Pharmaceutical Supply Chain, the Health Strategies Consultancy LLC for the Kaiser Family Foundation, March 2005
http://www.kff.org/rxdrugs/7296.cfm

Cost Containment Strategies for Prescription Drugs: Assessing the Evidence in the Literature, Jack Hoadley, Health Policy Institute, Georgetown University for the Kaiser Family Foundation, March 2005
http://www.kff.org/rxdrugs/7295.cfm

Prescription Drug Trends Fact Sheet, October 2004
http://www.kff.org/rxdrugs/3057-03.cfm

Other Resources on Medicare Formulary Issues

Guidelines for Reviewing Prescription Drug Plan Formularies and Procedures, U.S. Centers for Medicare & Medicaid Services, January 2005
http://www.cms.hhs.gov/pdps/FormularyGuidance.pdf

Medicare Prescription Drug Benefit Model Guidelines - Drug Categories and Classes in Part D, the United States Pharmacopeial Convention, Inc., December 2004
http://www.usp.org/pdf/drugInformation/mmg/finalModelGuidelines2004-12-31.pdf